Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections
- PMID: 19500529
- DOI: 10.1016/j.diagmicrobio.2009.03.002
Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections
Abstract
This comparison of intermittent versus extended-infusion piperacillin-tazobactam among patients with Gram-negative infections revealed similar mortality and length of stay. Outcomes remained similar when stratified by MIC value.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical